CHICAGO — Sterling Bay has unveiled plans to develop a 320,000-square-foot life sciences building within its Lincoln Yards mixed-use project in Chicago. Designed by Gensler, the facility will be situated along the North Branch of the Chicago River. The plans come on the heels of successful leasing activity at 2430 N. Halsted St., a redevelopment project that Sterling Bay undertook to create state-of-the-art lab space. The building is now more than 50 percent leased to Evozyne, Exicure Inc. and Vanqua Bio. Evozyne, a Chicago-based molecular engineering technology company, recently signed a 30,000-square-foot lease at the property. Evozyne’s space is scheduled for completion in early 2021. David Saad of CBRE represented Sterling Bay in the lease transaction with Evozyne.
Designed by Gensler, the facility will be situated along the North Branch of the Chicago River.
Sterling Bay Unveils Plans for 320,000 SF Life Sciences Building in Lincoln Yards Project
191